Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Sessine

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Urology|August 20, 2021
Editorial CommentMichael S Sessine, Jeffrey J Tosoian
The Journal of Urology|June 13, 2022
Editorial CommentMichael S Sessine, Nathan L Samora, Jeffrey J Tosoian
The Journal of Pathology|June 14, 2017
High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human diseaseYali Zhai, Rong Wu, Rork Kuick, et al.
The Journal of Pathology|May 28, 2019
Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epitheliumYisheng Wang, Michael S Sessine, Yali Zhai, et al.
The Journal of Urology|November 6, 2023
Can MRI Help Inform Which Men With a History of Multifocal High-Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?Michael S Sessine, Codrut S Radoiu, Ji Qi, et al.
Urology|May 16, 2020
Reframing Financial Incentives Around Reducing Readmission After Radical CystectomyMichael S Sessine, Alon Weizer, Peter S Kirk, et al.
Prostate Cancer and Prostatic Diseases|December 30, 2022
MyProstateScore in men considering repeat biopsy: validation of a simple testing approachJeffrey J Tosoian, Michael S Sessine, Bruce J Trock, et al.
Urology|July 19, 2021
Initial Findings from a High Genetic Risk Prostate Cancer ClinicMichael S Sessine, Sanjay Das, Bumsoo Park, et al.
Urology|December 15, 2021
Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical NeedJeffrey J Tosoian, Udit Singhal, Matthew S Davenport, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Urology|August 20, 2021
Editorial CommentMichael S Sessine, Jeffrey J Tosoian
The Journal of Urology|June 13, 2022
Editorial CommentMichael S Sessine, Nathan L Samora, Jeffrey J Tosoian
The Journal of Pathology|June 14, 2017
High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human diseaseYali Zhai, Rong Wu, Rork Kuick, et al.
The Journal of Pathology|May 28, 2019
Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epitheliumYisheng Wang, Michael S Sessine, Yali Zhai, et al.
The Journal of Urology|November 6, 2023
Can MRI Help Inform Which Men With a History of Multifocal High-Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?Michael S Sessine, Codrut S Radoiu, Ji Qi, et al.
Urology|May 16, 2020
Reframing Financial Incentives Around Reducing Readmission After Radical CystectomyMichael S Sessine, Alon Weizer, Peter S Kirk, et al.
Prostate Cancer and Prostatic Diseases|December 30, 2022
MyProstateScore in men considering repeat biopsy: validation of a simple testing approachJeffrey J Tosoian, Michael S Sessine, Bruce J Trock, et al.
Urology|July 19, 2021
Initial Findings from a High Genetic Risk Prostate Cancer ClinicMichael S Sessine, Sanjay Das, Bumsoo Park, et al.
Urology|December 15, 2021
Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical NeedJeffrey J Tosoian, Udit Singhal, Matthew S Davenport, et al.
Pageof 1